CANY
AMTX icon

Caxton Associates (New York)’s Aemetis AMTX Stock Holding History

Caxton Associates (New York)’s Portfolio AMTX Stock Details AMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-58,061
Closed -$1.42M – 466
2021
Q1 		$1.42M Buy
+58,061
New +$648K 0.13% 50

Other funds holding AMTX

ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Caxton Associates (New York)'s AMTX Position: Q2 2021 in Review

Caxton Associates (New York) sold out of Aemetis (AMTX) in Q2 2021, closing a stake of 58,061 shares — an estimated $1.42M sold.

Caxton Associates (New York) first reported a position in AMTX in Q1 2021 and held it in 1 quarter. The position peaked at $1.42M in Q1 2021. 81 funds tracked by Wall St. Rank hold AMTX as of Q2 2021.

  • Caxton Associates (New York) reported no remaining Aemetis position as of Q2 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 58,061 Aemetis shares in Q2 2021, an estimated $1.42M.
  • Caxton Associates (New York) first reported a position in Aemetis in Q1 2021 and held it in 1 quarter.
  • Caxton Associates (New York)'s Aemetis position peaked at $1.42M in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Aemetis as of Q2 2021.

Based on Caxton Associates (New York)'s 13F filing for Q2 2021, filed 16 Aug 2021.